251317-72-3

Upstream product

• 20850-49-1 2-(3,4-dimethoxyphenyl)-3-methylbutyronitrile 
• 36770-70-4 2-(3,4-dimethoxyphenyl)-5-hydroxy-2-(methylethyl)pentanenitrile 

Downstream Products

• 251317-73-4 5-(t-butoxycarbonyl)amino-4-(3,4-dimethoxyphenyl)-4-isopropyl-1-pentanol 
• 251317-75-6 N¹-t-butoxycarbonyl-2-(3,4-dimethoxyphenyl)-2-isopropyl-N⁵-(o-azido-phenethyl)-1,5-pentanediamine 
• 251317-77-8 N¹-t-butoxycarbonyl-2-(3,4-dimethoxyphenyl)-2-isopropyl-N⁵-(o-azido-phenethyl)-N⁵-methyl-1,5-pentanediamine 
• 251317-76-7 2-(3,4-dimethoxyphenyl)-2-isopropyl-N⁵-(o-azido-phenethyl)-1,5-pentanediamine 
• 251317-78-9 2-(3,4-dimethoxyphenyl)-2-isopropyl-N⁵-(o-azido-phenethyl)-N⁵-methyl-1,5-pentanediamine 
• 251317-74-5 1-[5-(t-butoxycarbonyl)amino-4-(3,4-dimethoxyphenyl)-4-isopropyl-1-pentyl] methanesulfonate 

Relevant academic research and scientific papers

Synthesis and binding properties of photoactivable biotin-conjugated verapamil derivatives for the study of P-170 glycoprotein

The design and synthesis of two photoactivable biotin-labeled analogues of verapamil (6 and 7) is reported. Preliminary evaluation of the biological profile of 6 (EDP 137) and 7 (EDP 141) shows that they have comparable affinities to that of verapamil for